Skrajna A, Bodrug T, Martinez-Chacin R, Fisher C, Welsh K, Simmons H
Nat Commun. 2025; 16(1):2561.
PMID: 40089476
DOI: 10.1038/s41467-025-57384-7.
He C, Zhou Z, Yang Y, Zhu S, Wang H, Teng L
Gastric Cancer. 2025; .
PMID: 40024947
DOI: 10.1007/s10120-025-01602-0.
Grigoreva T, Novikova D, Melino G, Barlev N, Tribulovich V
Biol Direct. 2024; 19(1):55.
PMID: 38978100
PMC: 11232244.
DOI: 10.1186/s13062-024-00497-8.
Chen Y, Vermeersch M, Van Leene J, De Jaeger G, Li Y, Vanhaeren H
Sci Adv. 2024; 10(11):eadj2570.
PMID: 38478622
PMC: 10936951.
DOI: 10.1126/sciadv.adj2570.
Ci M, Zhao G, Li C, Liu R, Hu X, Pan J
Cell Death Dis. 2024; 15(3):179.
PMID: 38429268
PMC: 10907623.
DOI: 10.1038/s41419-024-06569-x.
Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy.
Jiang Y, Ni S, Xiao B, Jia L
Acta Pharm Sin B. 2023; 13(11):4341-4372.
PMID: 37969742
PMC: 10638515.
DOI: 10.1016/j.apsb.2023.07.019.
Time-resolved cryo-EM (TR-EM) analysis of substrate polyubiquitination by the RING E3 anaphase-promoting complex/cyclosome (APC/C).
Bodrug T, Welsh K, Bolhuis D, Paulakonis E, Martinez-Chacin R, Liu B
Nat Struct Mol Biol. 2023; 30(11):1663-1674.
PMID: 37735619
PMC: 10643132.
DOI: 10.1038/s41594-023-01105-5.
UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma.
Wu J, Xu X, Wu S, Shi W, Zhang G, Cao Y
Cancer Med. 2023; 12(17):18078-18097.
PMID: 37563971
PMC: 10523983.
DOI: 10.1002/cam4.6431.
Structural Dynamics of Lys11-Selective Deubiquitinylase Cezanne-1 during the Catalytic Cycle.
Ilter M, Schulze-Niemand E, Naumann M, Stein M
J Chem Inf Model. 2023; 63(7):2084-2094.
PMID: 36943332
PMC: 10091412.
DOI: 10.1021/acs.jcim.2c01281.
From seeds to trees: how E2 enzymes grow ubiquitin chains.
Middleton A, Day C
Biochem Soc Trans. 2023; 51(1):353-362.
PMID: 36645006
PMC: 9987950.
DOI: 10.1042/BST20220880.
The UBE2D ubiquitin conjugating enzymes: Potential regulatory hubs in development, disease and evolution.
Roman-Trufero M, Dillon N
Front Cell Dev Biol. 2022; 10:1058751.
PMID: 36578786
PMC: 9790923.
DOI: 10.3389/fcell.2022.1058751.
A nomogram for predicting prognosis of multiple myeloma patients based on a ubiquitin-proteasome gene signature.
Ji D, Liu Y, Sun W, Shi Q, Chen G, Song Z
Aging (Albany NY). 2022; 14(24):9951-9968.
PMID: 36534449
PMC: 9831738.
DOI: 10.18632/aging.204432.
Affinity microfluidics enables high-throughput protein degradation analysis in cell-free extracts.
Brio L, Wasserman D, Michaely-Barbiro E, Barazany-Gal G, Gerber D, Tzur A
Commun Biol. 2022; 5(1):1147.
PMID: 36307570
PMC: 9616816.
DOI: 10.1038/s42003-022-04103-3.
Identification of the hub and prognostic genes in liver hepatocellular carcinoma bioinformatics analysis.
Gao Q, Fan L, Chen Y, Cai J
Front Mol Biosci. 2022; 9:1000847.
PMID: 36250027
PMC: 9557295.
DOI: 10.3389/fmolb.2022.1000847.
Role of circRNA in E3 Modification under Human Disease.
Chen Z, Song M, Wang T, Gao J, Lin F, Dai H
Biomolecules. 2022; 12(9).
PMID: 36139159
PMC: 9496110.
DOI: 10.3390/biom12091320.
The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.
Vaughan N, Scholz N, Lindon C, Licchesi J
Sci Rep. 2022; 12(1):13160.
PMID: 35915203
PMC: 9343455.
DOI: 10.1038/s41598-022-16965-y.
UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
Zhang M, Liu Y, Yin Y, Sun Z, Wang Y, Zhang Z
Mol Med. 2022; 28(1):62.
PMID: 35658829
PMC: 9166599.
DOI: 10.1186/s10020-022-00489-2.
Examining the mechanistic relationship of APC/C and its interphase inhibitor EMI1.
Bolhuis D, Martinez-Chacin R, Welsh K, Bodrug T, Cui L, Emanuele M
Protein Sci. 2022; 31(6):e4324.
PMID: 35634770
PMC: 9112349.
DOI: 10.1002/pro.4324.
Linkage reprogramming by tailor-made E3s reveals polyubiquitin chain requirements in DNA-damage bypass.
Wegmann S, Meister C, Renz C, Yakoub G, Wollscheid H, Takahashi D
Mol Cell. 2022; 82(8):1589-1602.e5.
PMID: 35263628
PMC: 9098123.
DOI: 10.1016/j.molcel.2022.02.016.
APC7 mediates ubiquitin signaling in constitutive heterochromatin in the developing mammalian brain.
Ferguson C, Urso O, Bodrug T, Gassaway B, Watson E, Prabu J
Mol Cell. 2021; 82(1):90-105.e13.
PMID: 34942119
PMC: 8741739.
DOI: 10.1016/j.molcel.2021.11.031.